Abstract
A 58-year-old woman with rheumatoid arthritis (RA) developed fever, skin eruptions, leukocytopenia, and thrombocytopenia, 3 weeks after treatment with sulfasalazine. A skin biopsy showed hydropic degeneration of keratinocytes and lymphocytic infiltrate. A bone marrow aspiration demonstrated an increased number of macrophages with hemophagocytosis. Although serologic tests for Epstein–Barr virus (EBV) indicated a previous infection, EBV deoxyribonucleic acid was detected in her serum by polymerase chain reaction. Cessation of sulfasalazine and administration of steroids led to dramatic improvement. This case illustrates that the hemophagocytic syndrome associated with reactivation of EBV can occur as part of drug hypersensitivity reactions in RA patients taking sulfasalazine.
This is a preview of subscription content, log in via an institution to check access.
Similar content being viewed by others
References
Vittorio CC, Muglia JJ (1995) Anticonvulsant hypersensitivity syndrome. Arch Intern Med 155:2285–2290
Pichler WJ (2003) Delayed drug hypersensitivity reactions. Ann Intern Med 139:683–693
Seishima M, Yamanaka S, Fujisawa T, Tohyama M, Hashimoto K (2006) Reactivation of human herpesvirus (HHV) family members other than HHV-6 in drug-induced hypersensitivity syndrome. Br J Dermatol 155:344–349
Tohyama M, Yahata Y, Yasukawa M, Inagi R, Urano Y, Yamanishi K et al (1998) Severe hypersensitivity syndrome due to sulfasalazine associated with reactivation of human herpesvirus 6. Arch Dermatol 134:1113–1117
Kunisaki Y, Goto H, Kitagawa K, Nagano M (2003) Salazosulfapyridine induced hypersensitivity syndrome associated with reactivation of human herpes virus 6. Intern Med 42:203–207
Descamps V, Mahe E, Houhou N, Abramowitz L, Rozenberg F, Ranger-Rogez S et al (2003) Drug-induced hypersensitivity syndrome associated with Epstein–Barr virus infection. Br J Dermatol 148:1032–1034
Halmos B, Anastopoulos HT, Schnipper LE, Ballesteros E (2004) Extreme lymphoplasmacytosis and hepatic failure associated with sulfasalazine hypersensitivity reaction and a concurrent EBV infection – case report and review of the literature. Ann Hematol 83:242–246
Takahashi N, Chubachi A, Kume M, Hatano Y, Komatsuda A, Kawabata Y et al (2001) A clinical analysis of 52 adult patients with hemophagocytic syndrome: the prognostic significance of the underlying diseases. Int J Hematol 74:209–213
Dhote R, Simon J, Papo T, Detournay B, Sailler L, Andre M-H et al (2003) Reactive hemophagocytic syndrome in adult systemic disease: report of twenty-six cases and literature review. Arthritis Rheum 49:633–639
Onishi R, Namiuchi S (1994) Hemophagocytic syndrome in a patient with rheumatoid arthritis. Intern Med 33:607–611
Sibilia J, Javier R-M, Albert A, Cazenave JP, Kuntz JL (1998) Pancytopenia secondary to hemophagocytic syndrome in rheumatoid arthritis treated with methotrexate and sulfasalazine. J Rheumatol 25:1218–1220
Descamps V, Bouscarat F, Laglenne S, Aslangul E, Veber B, Descamps D et al (1997) Human herpesvirus 6 infection associated with anticonvulsant hypersensitivity syndrome and reactive haemophagocytic syndrome. Br J Dermatol 137:605–608
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Komatsuda, A., Okamoto, Y., Hatakeyama, T. et al. Sulfasalazine-induced hypersensitivity syndrome and hemophagocytic syndrome associated with reactivation of Epstein–Barr virus. Clin Rheumatol 27, 395–397 (2008). https://doi.org/10.1007/s10067-007-0753-4
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s10067-007-0753-4